Two-year toxicity of hypofractionated breast cancer radiotherapy in five fractions

Acta Oncol. 2020 Jul;59(7):872-875. doi: 10.1080/0284186X.2020.1747638. Epub 2020 Apr 14.

Authors

Hans Van Hulle¹, Vincent Vakaet^{1

2}, Kathleen Deckmyn¹, Chris Monten^{1

2}, Leen Paelinck², Annick Van Greveling², Giselle Post¹, Max Schoepen^{1

3}, Arthur Fonteyne¹, Bruno Speleers¹, Pieter Deseyne^{1

2}, Marc Mareel¹, Wilfried De Neve^{1

2}, Liv Veldeman^{1

2}

Affiliations

¹ Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
² Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
³ Department of Industrial Systems Engineering and Product Design, Kortrijk, Belgium.

PMID: 32285729
DOI: 10.1080/0284186X.2020.1747638

No abstract available

Publication types

Letter

MeSH terms

Breast Neoplasms / drug therapy
Breast Neoplasms / radiotherapy*
Case-Control Studies
Chemotherapy, Adjuvant
Female
Fibrosis / etiology
Humans
Radiation Dose Hypofractionation*
Radiation Injuries / etiology
Retrospective Studies
Telangiectasis / etiology
Time Factors